Morphic Holding Inc (MORF)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

35 GATEHOUSE DRIVE A2 WALTHAM, MA 02451

Morphic Holding, Inc. operates as a holding company. The Company, through its subsidiaries, develops oral integrin drugs for patients suffering from serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding serves customers in the State of Massachusetts.

Data as of 2020-08-01
Market Cap689.867 Million Shares Outstanding30.647 Million Avg 30-day Volume103.226 Thousand
P/E Ratio Dividend Yield EPS-6.21
Price/Sales63.082 Price cash flow ratio9.3 Price free cash flow ratio-15.7
Book Value4.18 Price to Tangible Book5.9 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.059323
BETA0.877218 52-week High/Low33.5 / 9.9 Stddev0.223315
View SEC Filings from MORF instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 3 2 (0.13%)
13F Filers holding this stock: 47 15 (0.98%)
Aggregate 13F shares on 03/31/2020: 17.533 Million 11.68 Million
Aggregate 13F shares on 12/31/2019: 13.999 Million 8.964 Million
Percent change: 25.24% 30.29%
Funds creating new positions: 11 7
Funds Adding to an existing position: 20 4
Funds closing out their position: 2 2
Funds reducing their position: 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MORF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MORF BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

65 Thousand total shares from 20 transactions

Exercise Derivative Conversion (M)

12 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NOVO HOLDINGS A/S

  • 10% Owner
2,569,379 2020-07-28 0

GLAXOSMITHKLINE PLC

  • 10% Owner
4,626,389 2020-07-24 0

GOYAL VIKAS SEE REMARKS

  • Officer
87,764 2020-07-17 1

LUGOVSKOY ALEXEY CHIEF DEVELOPMENT OFFICER

  • Officer
105,248 2020-07-07 3

DEVAUL WILLIAM GENERAL COUNSEL AND SECRETARY

  • Officer
2,500 2020-07-07 3

SPRINGER TIMOTHY A

  • Director
  • 10% Owner
0 2020-06-19 2

BISCHOFBERGER NORBERT W

  • Director
0 2020-06-18 1

CHRISTENSEN GUSTAV

  • Director
0 2020-06-18 1

SLATTERY JOSEPH P

  • Director
0 2020-06-18 1

STAMPACCHIA OTELLO

  • Director
0 2020-06-18 1

NASHAT AMIR

  • Director
0 2020-06-18 1

ROGERS BRUCE CHIEF SCIENTIFIC OFFICER

  • Officer
153,319 2020-06-10 3

FARRELL ROBERT E JR SVP FINANCE AND CAO

  • Officer
77,934 2020-05-29 2

SCHEGERIN MARC CFO AND COO

  • Officer
2,000 2020-04-06 2

DALTON BARBARA

  • Director
  • 10% Owner
1,557,722 2020-03-16 0

LINDE PETER CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-16 2

TIPIRNENI PRAVEEN P. PRESIDENT AND CEO

  • Officer
  • Director
0 2020-02-18 1

OMEGA FUND V, L.P.

OMEGA FUND V GP, L.P.

OMEGA FUND V GP MANAGER, LTD.

LIM RICHARD J.

NESSI CLAUDIO

PASTER ANNE-MARI

STAMPACCHIA OTELLO

  • Director
  • 10% Owner
2,969,582 2019-07-01 0

KUMAR NILESH

  • Director
0 2019-06-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-09 S 513 $24.99 d 105,248 105,248.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-08 S 62 $25.75 d 2,500 2,500.00 direct yes

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-08 S 3,430 $24.82 d 105,961 105,248.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-08 M 856 d 181,854 2,500.00 direct

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-08 S 794 $24.77 d 2,562 2,500.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-08 M 856 $4.32 a 3,356 2,500.00 direct

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-08 S 200 $25.80 d 105,761 105,248.00 direct yes

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-07 S 4,396 $25.74 d 109,996 105,248.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-07 S 100 $26.65 d 2,500 2,500.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-07 S 1,161 $25.89 d 2,600 2,500.00 direct yes

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-07 S 605 $26.65 d 109,391 105,248.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-07 M 1,261 d 182,710 2,500.00 direct

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-07 M 1,261 $4.32 a 3,761 2,500.00 direct

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-06 S 4,304 $25.87 d 114,392 114,392.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-06 M 2,200 $4.32 a 4,700 2,500.00 direct

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-06 M 2,200 d 183,971 2,500.00 direct

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-06 S 2,200 $25.88 d 2,500 2,500.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-02 M 5,400 d 186,171 2,500.00 direct

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-02 S 100 $26.83 d 118,696 114,392.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-02 S 5,400 $26.51 d 2,500 2,500.00 direct yes

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-02 S 9,939 $26.47 d 118,796 114,392.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-02 M 5,400 $4.32 a 7,900 2,500.00 direct

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-01 S 1,706 $27.15 d 128,735 114,392.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-01 S 835 $27.14 d 2,500 2,500.00 direct yes

LUGOVSKOY ALEXEY - Officer CHIEF DEVELOPMENT OFFICER

2020-07-01 S 2,807 $26.18 d 130,441 114,392.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-01 M 2,283 d 191,571 2,500.00 direct

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-01 S 1,448 $26.15 d 3,335 2,500.00 direct yes

DEVAUL WILLIAM - Officer GENERAL COUNSEL AND SECRETARY

2020-07-01 M 2,283 $4.32 a 4,783 2,500.00 direct

GOYAL VIKAS - Director

2020-06-18 A 12,000 a 12,000 0.00 direct

SPRINGER TIMOTHY A - Director - > 10% Owner

2020-06-18 A 12,000 a 12,000 0.00 direct

CHRISTENSEN GUSTAV - Director

2020-06-18 A 12,000 a 12,000 0.00 direct

SLATTERY JOSEPH P - Director

2020-06-18 A 12,000 a 12,000 0.00 direct

STAMPACCHIA OTELLO - Director

2020-06-18 A 12,000 a 12,000 0.00 direct

NASHAT AMIR - Director

2020-06-18 A 12,000 a 12,000 0.00 direct

BISCHOFBERGER NORBERT W - Director

2020-06-18 A 12,000 a 12,000 0.00 direct

ROGERS BRUCE - Officer CHIEF SCIENTIFIC OFFICER

2020-06-10 S 21,301 $23.18 d 157,018 153,319.00 direct

ROGERS BRUCE - Officer CHIEF SCIENTIFIC OFFICER

2020-06-10 S 3,699 $24.19 d 153,319 153,319.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments